Conclusion. Using the iPhone, uHear is a feasible screening test to rule out significant hearing loss (PTA >40 dB). It is highly sensitive for
detecting threshold changes at high frequencies, making it reasonably well suited to detect presbycusis and ototoxic hearing loss from HIV,
tuberculosis therapy and chemotherapy. Portability and ease of use make it appropriate to use in developing world communities that lack
screening programmes.